drugset / Trial / NCT04829786

Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian Subjects

NCT04829786 ↗

Phase 1 Completed 18 enrolled Ipsen
RandomizedCrossoverQuadruple-blindTreatment

Summary

this study purpose is to assess safety, tolerability and the pharmacokinetic (PK) profile of palovarotene in healthy Japanese and matched (with respect to sex, age, and weight) non-Asian subjects aged 18 to 55 years.

Timeline

Start
2015-09-01
Primary completion
2015-10-23
Completion
2015-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Palovarotene Small molecule — Oral